tiprankstipranks
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
PremiumThe FlyAcumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
15d ago
Sage Therapeutics price target lowered to $9 from $11 at Morgan Stanley
Premium
The Fly
Sage Therapeutics price target lowered to $9 from $11 at Morgan Stanley
16d ago
SAGE Therapeutics Announces Strategic Reorganization Amid Executive Departures
Premium
Company Announcements
SAGE Therapeutics Announces Strategic Reorganization Amid Executive Departures
20d ago
Sage Therapeutics price target lowered to $14 from $25 at H.C. Wainwright
PremiumThe FlySage Therapeutics price target lowered to $14 from $25 at H.C. Wainwright
22d ago
Sage Therapeutics Reports Q3 Growth and Strategic Focus
Premium
Company Announcements
Sage Therapeutics Reports Q3 Growth and Strategic Focus
22d ago
Sage Therapeutics reports Q3 EPS ($1.53) , consensus ($1.53)
Premium
The Fly
Sage Therapeutics reports Q3 EPS ($1.53) , consensus ($1.53)
23d ago
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
PremiumThe FlyNike upgraded, PayPal downgraded: Wall Street’s top analyst calls
1M ago
Sage Therapeutics reinstated with a Market Perform at Raymond James
Premium
The Fly
Sage Therapeutics reinstated with a Market Perform at Raymond James
1M ago
Sage Therapeutics price target lowered to $8 from $9 at Wedbush
Premium
The Fly
Sage Therapeutics price target lowered to $8 from $9 at Wedbush
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100